Radiomic Biomarkers to Refine Risk Models for Distant Metastasis in HPV-related Oropharyngeal Carcinoma.

Explore this paper's citation graph

Summary

Radiomic biomarkers appear to classify DM risk for patients with nonmetastatic HPV-related OPC and could be used either alone or with other clinical characteristics in the assignment of DM risk in future HPV- related OPC clinical trials.

Type
article
Published
2018-11-01
Cited by
72
References
53

Keywords

Medicine, Concordance, Stage (stratigraphy), Proportional hazards model, Oncology

References

Cited by

Related papers